–
Outlook Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
0.06
(positive)
Change from FY21 to FY25
millions USD
FY21:
−51.7
FY22:
−63.1
FY23:
−53.1
FY24:
−71.7
FY25:
−67.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−51.5
FY22:
−63.8
FY23:
−55.9
FY24:
−111
FY25:
−107
(positive)
Change from FY21 to FY25
millions USD
FY21:
−53.2
FY22:
−66.0
FY23:
−59.0
FY24:
−75.4
FY25:
−64.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−53.2
FY22:
−66.1
FY23:
−59.0
FY24:
−75.4
FY25:
−62.4
All amounts in millions USD